These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 29337703)

  • 1. New antibiotics for ventilator-associated pneumonia.
    Bassetti M; Vena A; Castaldo N; Righi E; Peghin M
    Curr Opin Infect Dis; 2018 Apr; 31(2):177-186. PubMed ID: 29337703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New perspectives in the antibiotic treatment of mechanically ventilated patients with infections from Gram-negatives.
    Karvouniaris M; Pontikis K; Nitsotolis T; Poulakou G
    Expert Rev Anti Infect Ther; 2021 Jul; 19(7):825-844. PubMed ID: 33270485
    [No Abstract]   [Full Text] [Related]  

  • 3. New Antibiotics for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia.
    Bassetti M; Mularoni A; Giacobbe DR; Castaldo N; Vena A
    Semin Respir Crit Care Med; 2022 Apr; 43(2):280-294. PubMed ID: 35088403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New treatments of multidrug-resistant Gram-negative ventilator-associated pneumonia.
    Poulakou G; Lagou S; Karageorgopoulos DE; Dimopoulos G
    Ann Transl Med; 2018 Nov; 6(21):423. PubMed ID: 30581831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Update on Eight "New" Antibiotics against Multidrug-Resistant Gram-Negative Bacteria.
    Yusuf E; Bax HI; Verkaik NJ; van Westreenen M
    J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33806604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
    Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
    J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New therapeutic options for respiratory tract infections.
    Bassetti M; Righi E; Carnelutti A
    Curr Opin Infect Dis; 2016 Apr; 29(2):178-86. PubMed ID: 26871402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New agents for the treatment of infections with Gram-negative bacteria: restoring the miracle or false dawn?
    Wright H; Bonomo RA; Paterson DL
    Clin Microbiol Infect; 2017 Oct; 23(10):704-712. PubMed ID: 28893690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of multidrug-resistant Gram-negative skin and soft tissue infections.
    Jabbour JF; Sharara SL; Kanj SS
    Curr Opin Infect Dis; 2020 Apr; 33(2):146-154. PubMed ID: 32022742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015.
    Sader HS; Castanheira M; Flamm RK
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28069649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging drugs for nosocomial pneumonia.
    Liapikou A; Torres A
    Expert Opin Emerg Drugs; 2016 Sep; 21(3):331-41. PubMed ID: 27347712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to treat VAP due to MDR pathogens in ICU patients.
    Garnacho-Montero J; Corcia-Palomo Y; Amaya-Villar R; Martin-Villen L
    BMC Infect Dis; 2014 Nov; 14():135. PubMed ID: 25430700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New antibiotics for Gram-negative pneumonia.
    Bassetti M; Magnè F; Giacobbe DR; Bini L; Vena A
    Eur Respir Rev; 2022 Dec; 31(166):. PubMed ID: 36543346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GRam stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) trial: rationale and study protocol for a randomised controlled trial.
    Yoshimura J; Yamakawa K; Kinoshita T; Ohta Y; Morimoto T
    Trials; 2018 Nov; 19(1):614. PubMed ID: 30409160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of guidelines for the management of hospital-acquired and ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria.
    Cillóniz C; Dominedò C; Torres A
    Curr Opin Infect Dis; 2019 Dec; 32(6):656-662. PubMed ID: 31567412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of cilastatin + imipenem + relebactam as a therapeutic option for hospital-acquired and ventilator-associated bacterial pneumonia: evidence to date.
    Sellarès-Nadal J; Eremiev S; Burgos J; Almirante B
    Expert Opin Pharmacother; 2021 Aug; 22(12):1521-1531. PubMed ID: 34120547
    [No Abstract]   [Full Text] [Related]  

  • 17. Management and prevention of ventilator-associated pneumonia caused by multidrug-resistant pathogens.
    Grgurich PE; Hudcova J; Lei Y; Sarwar A; Craven DE
    Expert Rev Respir Med; 2012 Nov; 6(5):533-55. PubMed ID: 23134248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of novel antibacterial drugs to combat multiple resistant organisms.
    Bassetti M; Righi E
    Langenbecks Arch Surg; 2015 Feb; 400(2):153-65. PubMed ID: 25667169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging trends of nosocomial pneumonia in intensive care unit of a tertiary care public teaching hospital in Western India.
    Bhadade R; Harde M; deSouza R; More A; Bharmal R
    Ann Afr Med; 2017; 16(3):107-113. PubMed ID: 28671150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
    Werarak P; Kiratisin P; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.